Advertisement

Table of Contents

December 11, 2014; 124 (25)

INSIDE BLOOD COMMENTARIES

PLENARY PAPER

HOW I TREAT

CLINICAL TRIALS AND OBSERVATIONS

  • Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures
    David Garcia, John H. Alexander, Lars Wallentin, Daniel M. Wojdyla, Laine Thomas, Michael Hanna, Sana M. Al-Khatib, Paul Dorian, Jack Ansell, Patrick Commerford, Greg Flaker, Fernando Lanas, Dragos Vinereanu, Denis Xavier, Elaine M. Hylek, Claes Held, Freek W. A. Verheugt, Christopher B. Granger and Renato D. Lopes

HEMATOPOIESIS AND STEM CELLS

IMMUNOBIOLOGY

LYMPHOID NEOPLASIA

MYELOID NEOPLASIA

PLATELETS AND THROMBOPOIESIS

RED CELLS, IRON, AND ERYTHROPOIESIS

THROMBOSIS AND HEMOSTASIS

TRANSPLANTATION

  • Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS
    Christopher G. Kanakry, Hua-Ling Tsai, Javier Bolaños-Meade, B. Douglas Smith, Ivana Gojo, Jennifer A. Kanakry, Yvette L. Kasamon, Douglas E. Gladstone, William Matsui, Ivan Borrello, Carol Ann Huff, Lode J. Swinnen, Jonathan D. Powell, Keith W. Pratz, Amy E. DeZern, Margaret M. Showel, Michael A. McDevitt, Robert A. Brodsky, Mark J. Levis, Richard F. Ambinder, Ephraim J. Fuchs, Gary L. Rosner, Richard J. Jones and Leo Luznik

BLOOD WORK

CORRESPONDENCE